Literature DB >> 10747206

Neurotoxins affecting neuroexocytosis.

G Schiavo1, M Matteoli, C Montecucco.   

Abstract

Nerve terminals are specific sites of action of a very large number of toxins produced by many different organisms. The mechanism of action of three groups of presynaptic neurotoxins that interfere directly with the process of neurotransmitter release is reviewed, whereas presynaptic neurotoxins acting on ion channels are not dealt with here. These neurotoxins can be grouped in three large families: 1) the clostridial neurotoxins that act inside nerves and block neurotransmitter release via their metalloproteolytic activity directed specifically on SNARE proteins; 2) the snake presynaptic neurotoxins with phospholipase A(2) activity, whose site of action is still undefined and which induce the release of acethylcholine followed by impairment of synaptic functions; and 3) the excitatory latrotoxin-like neurotoxins that induce a massive release of neurotransmitter at peripheral and central synapses. Their modes of binding, sites of action, and biochemical activities are discussed in relation to the symptoms of the diseases they cause. The use of these toxins in cell biology and neuroscience is considered as well as the therapeutic utilization of the botulinum neurotoxins in human diseases characterized by hyperfunction of cholinergic terminals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747206     DOI: 10.1152/physrev.2000.80.2.717

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  352 in total

1.  Coincident spiking activity induces long-term changes in inhibition of neocortical pyramidal cells.

Authors:  C D Holmgren; Y Zilberter
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

2.  Homotypic fusion of immature secretory granules during maturation requires syntaxin 6.

Authors:  F Wendler; L Page; S Urbé; S A Tooze
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

3.  Progress in rapid screening of Bacillus anthracis lethal factor activity.

Authors:  Michèle Mock; Bernard P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

4.  Glycerotoxin from Glycera convoluta stimulates neurosecretion by up-regulating N-type Ca2+ channel activity.

Authors:  Frédéric A Meunier; Zhong-Ping Feng; Jordi Molgó; Gerald W Zamponi; Giampietro Schiavo
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

5.  Identification of SNARE complex modulators that inhibit exocytosis from an alpha-helix-constrained combinatorial library.

Authors:  Clara Blanes-Mira; Maria T Pastor; Elvira Valera; Gregorio Fernández-Ballester; Jaime M Merino; Luis M Gutierrez; Enrique Perez-Payá; Antonio Ferrer-Montiel
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

Review 6.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 7.  Mechanisms of storage and exocytosis in neuroendocrine tumors.

Authors:  Manfred Gratzl; Martin Breckner; Christian Prinz
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 8.  Pasteurella multocida toxin as a tool for studying Gq signal transduction.

Authors:  B A Wilson; M Ho
Journal:  Rev Physiol Biochem Pharmacol       Date:  2004-09-29       Impact factor: 5.545

9.  Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium.

Authors:  Sicai Zhang; Francois Lebreton; Michael J Mansfield; Shin-Ichiro Miyashita; Jie Zhang; Julia A Schwartzman; Liang Tao; Geoffrey Masuyer; Markel Martínez-Carranza; Pål Stenmark; Michael S Gilmore; Andrew C Doxey; Min Dong
Journal:  Cell Host Microbe       Date:  2018-01-27       Impact factor: 21.023

Review 10.  Evidence based medicine on the use of botulinum toxin for headache disorders.

Authors:  W J Schulte-Mattler; E Leinisch
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.